May 7, 2021
Waiving IP Protection for COVID Vaccines Is Anti-Innovation and Anti–Public Health
Patent rights were key to the unprecedentedly rapid development and rollout of COVID-19 vaccines.
Read more at National Review.
Read more at National Review.
Comment on Draft Policy Statement on Licensing Negotiations and Remedies for Standards-Essential Patents Subject to F/RAND Commitments | Regulations.gov
Alden Abbott